Skip to Main content Skip to Navigation
Journal articles

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment

Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00995738
Contributor : Ed. Bmc <>
Submitted on : Friday, May 23, 2014 - 5:14:20 PM
Last modification on : Wednesday, August 19, 2020 - 12:08:09 PM
Long-term archiving on: : Monday, August 25, 2014 - 11:36:16 AM

Files

Identifiers

  • HAL Id : inserm-00995738, version 1

Collections

Citation

Anne-Sophie Chantry, M Tching-Sin, Catherine Dhiver, Thierry Allegre, Jean-Marie Ruiz, et al.. Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment. BMC Infectious Diseases, BioMed Central, 2014, 14 (Suppl 2), pp.P83. ⟨inserm-00995738⟩

Share

Metrics

Record views

389

Files downloads

1039